L1 Global Manager Pty Ltd bought a new stake in GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 567,566 shares of the company’s stock, valued at approximately $6,067,000. GP-Act III Acquisition makes up approximately 4.0% of L1 Global Manager Pty Ltd’s holdings, making the stock its 4th biggest position.
A number of other institutional investors and hedge funds have also recently bought and sold shares of GPAT. Cannon Global Investment Management LLC increased its holdings in shares of GP-Act III Acquisition by 38.1% during the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock worth $155,000 after buying an additional 4,000 shares during the last quarter. Verition Fund Management LLC increased its holdings in shares of GP-Act III Acquisition by 2.2% during the 3rd quarter. Verition Fund Management LLC now owns 227,624 shares of the company’s stock worth $2,413,000 after buying an additional 4,974 shares during the last quarter. Linden Advisors LP acquired a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth $8,454,000. Clear Street Group Inc. acquired a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth $109,000. Finally, Bank of America Corp DE acquired a new stake in shares of GP-Act III Acquisition during the 3rd quarter worth $85,000.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.
GP-Act III Acquisition Trading Up 0.1%
Shares of NASDAQ GPAT opened at $10.84 on Friday. GP-Act III Acquisition Corp. has a 12-month low of $10.42 and a 12-month high of $12.00. The stock has a fifty day moving average price of $10.88 and a 200 day moving average price of $10.78.
GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.06 earnings per share (EPS) for the quarter.
GP-Act III Acquisition Company Profile
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Featured Articles
- Five stocks we like better than GP-Act III Acquisition
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report).
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
